Live Analyst Rating Changes 8035 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ronald Kamdem
MS
Ronald Kamdem
Wall Street Analyst
★★★☆☆
#818
on 13Foresight · ranked by our own returns
67%
Success Rate
+2.7%
Average Return
38 of 57 calls profitable · -2.9% vs benchmark
📈 Across the calls we could measure, roughly 67% of Ronald Kamdem's ratings turned a profit when each position was held for 1 year — averaging +2.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

49 Buy 118 Hold 22 Sell
Ronald's Stock Coverage 40 ratings · 2026-07-13
Company Date Position Consensus Price Target 1-Yr Return
PECO
Phillips Edison & Company
Jul 10, 2026 HOLD Buy
+1.4% avg upside
17 analysts
$42.00
0.29% Upside
·
FVR
FrontView REIT, Inc.
Jul 08, 2026 HOLD Buy
-5.9% avg upside
10 analysts
$21.00
0.74% Upside
·
VICI
VICI Properties
Jul 08, 2026 HOLD Strong Buy
+31.3% avg upside
33 analysts
$31.00
19.23% Upside
-0.9%
GLPI
Gaming and Leisure
Jul 07, 2026 HOLD Strong Buy
+23.1% avg upside
34 analysts
$55.00
27.43% Upside
-2.0%
CBRE
CBRE Group
Jun 18, 2026 BUY Strong Buy
-1.1% avg upside
24 analysts
$180.00
29.06% Upside
+6.1%
CURB
Curbline Properties Corp.
Jun 18, 2026 HOLD Strong Buy
-0.1% avg upside
11 analysts
$30.00
1.41% Downside
+1.8%
MAC
Macerich
Jun 18, 2026 HOLD Buy
+37.2% avg upside
25 analysts
$25.00
1.33% Upside
+4.5%
KIM
Kimco Realty
Jun 16, 2026 HOLD Buy
-0.8% avg upside
33 analysts
$24.00
3.50% Downside
-0.5%
REG
Regency Centers
Jun 16, 2026 BUY Buy
+1.0% avg upside
28 analysts
$88.00
10.45% Upside
+1.3%
DOC
Healthpeak Properties
Jun 12, 2026 HOLD Buy
+7.6% avg upside
43 analysts
$22.00
1.64% Upside
+6.5%
ARE
Alexandria Equities
Jun 11, 2026 SELL Buy
+52.6% avg upside
26 analysts
$53.00
10.71% Upside
+7.5%
AHR
American Healthcare REIT, Inc.
Jun 11, 2026 BUY Strong Buy
-3.4% avg upside
16 analysts
+15.6%
WELL
Welltower
Jun 11, 2026 BUY Strong Buy
-20.2% avg upside
33 analysts
+9.9%
SPG
Simon Property
Jun 09, 2026 HOLD Buy
-5.4% avg upside
30 analysts
$207.00
5.42% Downside
+3.8%
VTR
Ventas
Jun 02, 2026 HOLD Strong Buy
-9.2% avg upside
35 analysts
$90.00
0.77% Downside
+16.2%
EXR
Extra Space Storage
Jun 02, 2026 HOLD Buy
+3.8% avg upside
30 analysts
$155.00
7.71% Upside
+2.3%
EGP
Eastgroup Properties
Jun 01, 2026 HOLD Strong Buy
-5.1% avg upside
31 analysts
$231.00
10.17% Upside
+9.8%
LINE
Lineage, Inc.
Jun 01, 2026 HOLD Hold
+7.0% avg upside
21 analysts
$47.00
9.08% Upside
-0.9%
SNDA
Sonida Senior Living
May 29, 2026 HOLD Buy
+122.7% avg upside
12 analysts
$38.00
6.13% Downside
+13.2%
PLD
Prologis
May 27, 2026 HOLD Strong Buy
+3.1% avg upside
32 analysts
$151.00
7.22% Upside
-3.3%
JAN
Janus Living, Inc. Class A
May 20, 2026 BUY Strong Buy
+3.0% avg upside
11 analysts
$28.00
2.42% Downside
·
NHP
National Healthcare Properties
May 18, 2026 HOLD Buy
+13.7% avg upside
8 analysts
$16.00
6.99% Upside
·
VNO
Vornado Realty
May 05, 2026 HOLD Buy
-11.8% avg upside
21 analysts
$28.00
27.06% Downside
+34.5%
NNN
NNN REIT
May 04, 2026 BUY Hold
-2.5% avg upside
29 analysts
$50.00
6.99% Upside
+6.2%
BNL
Broadstone Net Lease
Apr 30, 2026 HOLD Strong Buy
+0.4% avg upside
14 analysts
$24.00
9.89% Upside
+12.0%
O
Realty Income
Apr 27, 2026 HOLD Buy
+5.8% avg upside
38 analysts
$67.00
5.82% Upside
+2.2%
ADC
Agree Realty
Apr 21, 2026 HOLD Strong Buy
+1.9% avg upside
29 analysts
$81.00
3.89% Upside
-0.1%
HIW
Highwoods Properties
Mar 31, 2026 HOLD Buy
+5.9% avg upside
18 analysts
$23.00
26.26% Downside
+48.7%
AAT
American Assets
Mar 31, 2026 SELL Buy
+39.9% avg upside
8 analysts
$18.00
28.37% Downside
-38.6%
SLG
SL Green Realty
Mar 31, 2026 HOLD Buy
+9.0% avg upside
29 analysts
$36.00
26.08% Downside
+32.5%
HPP
Hudson Pacific Properties
Mar 31, 2026 SELL Hold
+18.2% avg upside
24 analysts
$5.00
67.02% Downside
-156.8%
BXP
BXP
Mar 31, 2026 HOLD Buy
+20.6% avg upside
35 analysts
$60.00
10.22% Downside
+33.5%
NSA
National Storage Affiliates
Feb 26, 2026 HOLD Hold
-15.0% avg upside
25 analysts
$32.00
28.53% Downside
+33.1%
SAFE
Safehold
Jan 22, 2026 SELL Buy
+31.1% avg upside
15 analysts
$14.00
13.18% Downside
-9.1%
CWK
Cushman & Wakefield
Jan 16, 2026 BUY Buy
+21.4% avg upside
17 analysts
$19.00
40.89% Upside
-25.1%
UE
Urban Edge Properties
Jan 05, 2026 HOLD Buy
-2.8% avg upside
9 analysts
$22.00
3.34% Downside
+23.8%
PSA
Public Storage
Dec 05, 2025 HOLD Buy
-1.5% avg upside
29 analysts
$290.00
9.50% Downside
+21.2%
RMAX
Re/Max Holdings
Feb 21, 2025 SELL Hold
+134.8% avg upside
14 analysts
$7.50
29.14% Downside
+25.9%
SITC
SITE Centers
Jan 16, 2025 HOLD Hold
+427.8% avg upside
19 analysts
$15.00
249.67% Upside
-16.3%
RMR
The RMR Group
Jan 15, 2025 HOLD Hold
+20.6% avg upside
9 analysts
$24.00
17.05% Upside
-5.5%
🔒 35 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ronald Kamdem — Frequently Asked Questions
How accurate are Ronald Kamdem's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Ronald's ratings were profitable over a one-year hold, with an average return of +2.8% per rating, or -3.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ronald ranked on 13Foresight?
Ronald Kamdem is currently ranked #818 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ronald cover?
Ronald most recently has ratings on PECO, FVR, VICI, GLPI, CBRE, CURB, MAC, KIM, REG, DOC, ARE, AHR and 28 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.